Northwestern Mutual Wealth Management Company »

Protagonist Therapeutics shares owned by Northwestern Mutual Wealth Management Company

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Northwestern Mutual Wealth Management Company from 13F filings

Historical chart of Northwestern Mutual Wealth Management Company investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Northwestern Mutual Wealth Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Northwestern Mutual Wealth Management Company

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.0M 79k 38.60
2024-09-30 $3.6M 79k 45.00
2024-06-30 $5.5M 158k 34.65
2021-12-31 $1.0k 16 62.50

More positions owned by Northwestern Mutual Wealth Management Company

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core S&p Mcp Etf (IJH)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Tr Core S&p Scp Etf (IJR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Msci Usa Value (VLUE)
Ishares Msci Eurzone Etf (EZU)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)

View all positions for Northwestern Mutual Wealth Management Company

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Group
State Street Corporation
Johnson & Johnson
BVF
Pacer Advisors
Leucadia National Corporation
T. Rowe Price Associates
Geode Capital Management
Perceptive Advisors
ADAR1 Capital Management
Wellington Management Company
American Century Companies

View all funds holding Protagonist Therapeutics